#1 Prescribed DMT for MS patients starting or switching to a new therapy 1*

NUMBER OF PATIENTS STARTING OR SWITCHING TO A NEW THERAPY

*From July 2017 to July 2019; Symphony Health, rolling 3-month prescriber-based data; includes both naïve and switch patients. Includes all patients with an ICD-10-CM of G35 (multiple sclerosis).
From January 2018 to June 2019; Symphony Health, average quarterly prescriber-based data. OCREVUS and the top DMT in each therapy delivery class are illustrated as lines in the chart. The data analyzed include all FDA-approved DMTs for MS as of June 2019.

Over 5 years of patient experience with OCREVUS

Patients prescribed OCREVUS

Examine RMS trial data

Learn about the treatment of all forms of RMS with OCREVUS.

Examine PPMS trial data

Learn more about the treatment of PPMS with OCREVUS.

Request information

Speak to an OCREVUS Representative to learn more about OCREVUS.

DMT=disease-modifying therapy; PPMS=primary progressive multiple sclerosis; RMS=relapsing multiple sclerosis.